---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-104541"
form_type: "8-K"
ticker: "CGTX"
cik: "0001455365"
company_name: "COGNITION THERAPEUTICS INC"
filed_at: "2024-10-01T23:59:59+00:00"
generated_at: "2026-05-30T23:16:09.774609+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "low"
source: SEC EDGAR
---

# Cognition Therapeutics furnishes investor presentation on amyloid beta oligomer approach

## Summary
- Presentation titled 'Targeting Amyloid Beta Oligomers: A Disruptive Approach to the Treatment of CNS Disorders' dated September 2024 made available.
- No specific financial results, clinical data, or guidance changes disclosed in filing or exhibit.
- Presentation furnished for Regulation FD; not incorporated by reference into SEC filings.

## SEC filing metadata
- accession: 0001104659-24-104541
- form_type: 8-K
- ticker: CGTX
- cik: 0001455365
- company_name: COGNITION THERAPEUTICS INC
- filed_at: 2024-10-01T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1455365/000110465924104541/0001104659-24-104541-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1455365/000110465924104541/tm2425259d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-104541
- JSON: https://secwatch.observer/filing/0001104659-24-104541.json
- Plain text: https://secwatch.observer/filing/0001104659-24-104541.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.